Company: INTS
Filing Date: 2025-06-13
Form Type: 8-K
Source: 0001628280-25-031311
Chunk: 3

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-06-13
Form: 8-K
Item: Item 8.01
Chunk 3
---
Item 8.01

Other Events.

On June 11, 2025, the Company issued a press release announcing the launch of the Offering, and on June 11, 2025, the Company issued a press release announcing the pricing of the Offering. Copies of the press releases are attached as Exhibits 99.1 and 99.2 hereto, respectively.

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements that involve estimates, assumptions, risks and uncertainties. Forward-looking statements include, but are not limited to, statements related to the amount of proceeds expected from the Offering. The risks and uncertainties relating to the Company and the Offering include the risks detailed from time to time in the Company’s filings with the SEC, including in its Annual Report on Form 10-K for the year ended December 31, 2024 and the Prospectus Supplement. These documents contain important factors that could cause actual results to differ from current expectations and from the forward-looking statements contained in this Current Report on Form 8-K. These forward-looking statements speak only as of the date of this Current Report on Form 8-K and the Company undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.